Fexofenadine for heart attack recovery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a type of heart attack called STEMI within the last 7 days.
- You understand the risks and benefits and agree to take part.
- You have not had bypass surgery or long-term use of similar allergy drugs.
- You do not have severe kidney or liver problems, active infection, or cancer.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
This trial tests if a traditional Chinese medicine pill (Shexiang Baoxin) can help people having a heart attack. It is given along with standard care, including a procedure to open blocked heart arteries (PCI).
This trial tests whether adding fexofenadine, a common allergy medicine, to your current Parkinson's treatment can help improve symptoms. It's for people aged 50 or older who are already on dopamine replacement therapy.
This trial tests if Qishenyiqi, a Chinese herbal medicine, can help your heart rebuild and work better after a heart attack. It is for people whose heart function is still weak and who have heart failure symptoms.
This trial tests whether Guanxinning Tablet, a Chinese herbal medicine, can improve blood flow in the tiny vessels of the heart after an acute heart attack (STEMI) treated with emergency angioplasty. The study measures heart function changes over 6 months using imaging.
This trial tests if a traditional Chinese herbal formula (Fuzheng Yangxin Prescription) can help people recover faster after coronary artery bypass surgery. It is for people who have a specific pattern of symptoms (called Qi-Yin deficiency) after their operation.
Hear when a new Zhejiang University trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.